MARKET

TNDM

TNDM

Tandem Diabetes
NASDAQ
50.30
+3.77
+8.10%
Closed 19:30 09/28 EDT
OPEN
47.31
PREV CLOSE
46.53
HIGH
50.37
LOW
47.09
VOLUME
1.43M
TURNOVER
--
52 WEEK HIGH
155.86
52 WEEK LOW
42.90
MARKET CAP
3.23B
P/E (TTM)
-240.5548
1D
5D
1M
3M
1Y
5Y
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Benzinga · 6d ago
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Gainers
Benzinga · 09/22 08:04
Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
Key leadership appointments focused on enhancing connections and collaboration to drive Innovation across the next-generation delivery of clinical trials and fuel more integrated, therapeutically-focused solutions for patientsBOSTON and DURHAM, N.C., Sept....
GlobeNewswire · 09/14 13:00
Why ShiftPixy Surges Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
Benzinga · 09/09 08:13
Where Tandem Diabetes Care Stands With Analysts
Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings within the last quarter:
Benzinga · 09/07 18:06
OTR Global Downgrades Tandem Diabetes Care to Mixed
OTR Global downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Positive to Mixed.
Benzinga · 09/07 17:18
As Tandem Diabetes Care, Inc.'s market cap (NASDAQ:TNDM) drops to US$2.9b, insiders might be questioning their decision to buy earlier this year
Insiders who acquired US$511k worth of Tandem Diabetes Care, Inc.'s ( NASDAQ:TNDM ) stock at an average price of...
Simply Wall St. · 09/05 12:13
Tandem Diabetes Care Announces Upcoming Conference Presentations
SAN DIEGO, August 22, 2022--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
Business Wire · 08/22 20:05
More
About TNDM
Tandem Diabetes Care, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of technology solutions for people living with diabetes. The Company's manufacturing, sales, and support activities principally focus on its flagship pump platform, the t:slim X2, and its complementary product offerings. Its t:slim X2 is based on Company's technology platform and is the smallest durable insulin pump available in the United States. The Company has commercially offered two different automated insulin dosing (AID) algorithms on t:slim X2, including Control-IQ technology, which is an advanced hybrid-closed loop feature, designed to help increase a user's time in their targeted glycemic range, and Food and Drug Administration (FDA) to deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar based on continuous glucose monitoring (CGM) readings.

Webull offers kinds of Tandem Diabetes Care Inc stock information, including NASDAQ:TNDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TNDM stock methods without spending real money on the virtual paper trading platform.